BASF Reportedly Raises Bid for Evonik Above €11 Billion
BASF has reportedly sweetened its offer for Evonik, pushing the deal value past €11 billion, sending Evonik shares higher.
If you've been watching the European chemicals sector, here's a deal worth paying attention to: BASF has reportedly upped its acquisition offer for rival Evonik to more than €11 billion, according to reports that sent Evonik's stock climbing on the news.
For context, both BASF and Evonik are heavyweight German specialty and industrial chemicals companies. A deal of this size would represent one of the more significant consolidation moves in the European chemicals industry in recent memory — the kind of thing that reshapes supply chains and competitive dynamics across multiple markets.
Read more Cardano Holders Asked to Stake $5M on Copper Price Record →
The bump in the offer price suggests BASF is serious about getting this deal done. When an acquirer increases its bid, it's usually a signal that initial talks hit some resistance — either from the target's board, major shareholders, or both — and the buyer decided the asset was worth paying up for rather than walking away.
Evonik shares gained on the report, which is exactly the market reaction you'd expect. When a credible higher offer surfaces, the stock tends to move toward that new price level as investors bet the deal gets done at or near the revised figure. Whether this revised number is enough to get all key stakeholders across the finish line remains to be seen.
Continue reading at SeekingAlpha.
